Using prior knowledge from cellular pathways and molecular networks for diagnostic specimen classification.

Area of Science:

• Biomedical Informatics
• Computational Biology
• Genomics

Background:

• Accurate diagnosis of complex diseases like cancers and neurodegenerative disorders is crucial for effective therapy development.
• Classical statistical learning methods using omics data often lack the accuracy and robustness needed for heterogeneous diseases.
• Limitations in current diagnostic models necessitate novel approaches for specimen classification.

Purpose of the Study:

• To survey recent advancements in multivariate biomarker model development using omics data.
• To compare pathway- and network-based specimen classification approaches.
• To evaluate the utility of these approaches in improving model robustness, accuracy, and biological interpretability.

Main Methods:

• Review of recent literature on pathway- and network-based approaches for omics data analysis.
• Comparative analysis of different methods for specimen classification.
• Discussion of strategies for translating biomarker models into clinical diagnostic tests.

Main Results:

• Pathway- and network-based methods offer improved robustness and accuracy over classical approaches.
• Integration of biological knowledge enhances the biological interpretability of diagnostic models.
• These advanced methods hold promise for earlier and more reliable disease diagnosis.

Conclusions:

• Network- and pathway-informed omics data analysis represents a significant advancement in specimen classification.
• These approaches are vital for developing more effective diagnostic tools for complex diseases.
• Translating these models into clinical practice can lead to improved patient outcomes through earlier intervention.